ES374929A1 - Procedimiento para la preparacion de l-3-(3,4-dihidroxife- nil)-alamina. - Google Patents

Procedimiento para la preparacion de l-3-(3,4-dihidroxife- nil)-alamina.

Info

Publication number
ES374929A1
ES374929A1 ES374929A ES374929A ES374929A1 ES 374929 A1 ES374929 A1 ES 374929A1 ES 374929 A ES374929 A ES 374929A ES 374929 A ES374929 A ES 374929A ES 374929 A1 ES374929 A1 ES 374929A1
Authority
ES
Spain
Prior art keywords
salts
group
dihydroxyphenyl
racemate
alanine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES374929A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES374929A1 publication Critical patent/ES374929A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • EFIXED CONSTRUCTIONS
    • E04BUILDING
    • E04CSTRUCTURAL ELEMENTS; BUILDING MATERIALS
    • E04C2/00Building elements of relatively thin form for the construction of parts of buildings, e.g. sheet materials, slabs, or panels
    • E04C2/02Building elements of relatively thin form for the construction of parts of buildings, e.g. sheet materials, slabs, or panels characterised by specified materials
    • E04C2/26Building elements of relatively thin form for the construction of parts of buildings, e.g. sheet materials, slabs, or panels characterised by specified materials composed of materials covered by two or more of groups E04C2/04, E04C2/08, E04C2/10 or of materials covered by one of these groups with a material not specified in one of the groups
    • EFIXED CONSTRUCTIONS
    • E04BUILDING
    • E04CSTRUCTURAL ELEMENTS; BUILDING MATERIALS
    • E04C2/00Building elements of relatively thin form for the construction of parts of buildings, e.g. sheet materials, slabs, or panels
    • E04C2/30Building elements of relatively thin form for the construction of parts of buildings, e.g. sheet materials, slabs, or panels characterised by the shape or structure
    • E04C2/38Building elements of relatively thin form for the construction of parts of buildings, e.g. sheet materials, slabs, or panels characterised by the shape or structure with attached ribs, flanges, or the like, e.g. framed panels

Landscapes

  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Architecture (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Structural Engineering (AREA)
  • Civil Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES374929A 1968-12-27 1969-12-26 Procedimiento para la preparacion de l-3-(3,4-dihidroxife- nil)-alamina. Expired ES374929A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78756368A 1968-12-27 1968-12-27

Publications (1)

Publication Number Publication Date
ES374929A1 true ES374929A1 (es) 1972-04-01

Family

ID=25141894

Family Applications (1)

Application Number Title Priority Date Filing Date
ES374929A Expired ES374929A1 (es) 1968-12-27 1969-12-26 Procedimiento para la preparacion de l-3-(3,4-dihidroxife- nil)-alamina.

Country Status (13)

Country Link
US (1) US3734952A (es)
BE (1) BE743496A (es)
CH (1) CH529098A (es)
CS (1) CS153057B2 (es)
DE (1) DE1964422A1 (es)
ES (1) ES374929A1 (es)
FR (1) FR2027208A1 (es)
GB (1) GB1292975A (es)
HU (1) HU162412B (es)
IE (1) IE33679B1 (es)
IL (1) IL33533A0 (es)
NL (1) NL6919271A (es)
SU (1) SU379085A3 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH562199A5 (es) * 1970-10-30 1975-05-30 Hoffmann La Roche
US4005127A (en) * 1971-03-08 1977-01-25 Monsanto Company L-Dopa process and intermediates
US3941831A (en) * 1973-09-10 1976-03-02 G. D. Searle & Co. Resolution of alkyl esters of DL-phenylalanine
US3891696A (en) * 1973-11-02 1975-06-24 Interx Research Corp Novel, transient pro-drug forms of l-dopa
US4151198A (en) * 1978-06-02 1979-04-24 American Cyanamid Company Resolution of N-acyl-DL (+)-phenylalanines
US4833273A (en) * 1986-02-03 1989-05-23 Warner-Lambert Company Process for the resolution of 1-aminoindanes
AU2003233147B2 (en) 2002-05-13 2008-03-06 Arexis Ab Autoimmune conditions and NADPH oxidase defects

Also Published As

Publication number Publication date
NL6919271A (es) 1970-06-30
IE33679B1 (en) 1974-09-18
CH529098A (de) 1972-10-15
SU379085A3 (es) 1973-04-18
US3734952A (en) 1973-05-22
CS153057B2 (es) 1974-02-22
IE33679L (en) 1970-06-27
BE743496A (es) 1970-06-22
IL33533A0 (en) 1970-02-19
FR2027208A1 (es) 1970-09-25
HU162412B (es) 1973-02-28
GB1292975A (en) 1972-10-18
DE1964422A1 (de) 1970-07-16

Similar Documents

Publication Publication Date Title
ES374929A1 (es) Procedimiento para la preparacion de l-3-(3,4-dihidroxife- nil)-alamina.
CH460044A (de) Verfahren zur Herstellung neuer heterocyclischer Verbindungen
AT293366B (de) Verfahren zur Herstellung von L-3-(3,4-Dihydroxyphenyl)-alanin
CH505837A (de) Verfahren zur Herstellung von neuen racemischen oder optisch aktiven Piperazinderivaten
ES388881A1 (es) Procedimiento para la preparacion de 1-(2-nitrilafenoxi)-2-hidroxi-3-etilaminopropano racemicos u opticamente activo.
BE798178A (fr) Derives d'acides phosphoniques substitues utilisables notamment comme agents ignifugeants
AT325631B (de) Verfahren zur herstellung von 1-(5-alkyl-1,3,4-thiadiazol-2-yl)-1,3-dialkyl-harnstoffen
AT269137B (de) Verfahren zur Herstellung neuer Oxazolidinderivate
ES385918A1 (es) Procedimiento para la preparacion de nuevos acilderivados de bis-arilalcohilaminas sustituidas.
ES378205A1 (es) Procedimiento para la preparacion de nuevos 2-amino-5-ni- trotiazoles sustituidos en el grupo amino.
GB1244682A (en) Anti-viral agents
CH529775A (de) Verfahren zur Herstellung von 2-substituierten 3-Chlor-1,2,4-thiaimidazol-5-onen
FR2096376A1 (en) Phenyl alanine derivs for treating parkinsonism
AT306052B (de) Verfahren zur Herstellung von neuer (cis-1,2-Epoxypropyl)-phosphonsäure oder entsprechenden Salzen oder Esterderivaten davon
ES428270A1 (es) Procedimiento de preparacion del sec. butil-2-metil-1 nitro-5 imidazol.
AT265522B (de) Verfahren zur Herstellung von stabilen wässerigen Injektionslösungen von 1-Alkyl-2-pyridinium-aldoxim-salzen
CH503751A (de) Verfahren zur Herstellung neuer Alkylammoniumsalze von 1,2,4-Triazolen
AT308742B (de) Verfahren zur Herstellung neuer heterocyclischer Verbindungen oder Salze davon
AT313258B (de) Verfahren zur Herstellung von optisch aktivem 3,4-Dihydroxyphenylalanin
ES392899A1 (es) Un metodo de preparar una composicion herbicida selectiva.
CH515937A (de) Verfahren zur Herstellung von Mischungen aus (+)- und (-)- Enantiomeren oder dem (+/-)-Racemat neuer (cis-1,2-Epoxypropyl)-phosphonsäurederivate
CH555349A (de) Verfahren zur herstellung neuer substituierter isothiocyanate des benztriazols mit hoher antimikrobieller wirksamkeit.
AT270081B (de) Verfahren zur Herstellung von neuen racemischen oder optisch aktiven Scopolammoniumsalzen
ES420716A1 (es) Procedimiento para la obtencion de dibenzazecinas.
ES353377A1 (es) Mejoras introducidas en un procedimiento para la elaboracion de un material de diazotipia de un solo componente